EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Utility of MALDI ‐ ToF MS for Recognition and Antifungal Susceptibility of Nannizzia , an Underestimated Group of Dermatophytes

Chao Tang, Xue Kong, Jasmijn Jansen, Katharina Vossgroene, Thi-Lam-An Vu, Boris Oberheitmann, Marlou Tehupeiory-Kooreman, Shaoqin Zhou, Xin Zhou, Clement Kin-Ming Tsui, Weida Liu, Yingqian Kang und 2 weitere

Mycoses · 2025

DOI: 10.1111/myc.70117 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Mycoses, 2025. Verfasst von Chao Tang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Guizhou Key Laboratory of Microbiome and Infectious Disease Prevention and Control & Key Laboratory of Environmental Pollution Monitoring and Disease…. Hauptthemen laut MEDLINE: Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization, Antifungal Agents, Arthrodermataceae. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: 111 Project, National Natural Science Foundation of China, International Science and Technology Cooperation Base of Guizhou Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Geophilic Nannizzia dermatophytes are increasingly implicated in stubborn skin, hair, and nail infections, yet MALDI‐TOF MS evaluations and antifungal‐susceptibility data have focused almost exclusively on N. gypsea . Biochemical profiles and MICs cut‐offs are limited.

Objectives

To benchmark two commercial MALDI‐TOF MS libraries and to determine in vitro activity of eight antifungals against a genus‐wide panel of Nannizzia species.

Methods

One‐hundred‐and‐three ITS‐confirmed isolates representing 12 species were grown on potato‐dextrose agar (PDA) for 7–14 days. Spectra were acquired with (i) the MSI‐2 Dermatophyte Library after 4–14 days' PDA incubation (100 cultures) and (ii) the Bruker MALDI Biotyper Filamentous‐Fungi Library 6.0/2023 after ≤ 3 days' growth in Sabouraud‐dextrose broth (SDB) (73 cultures). BCCM/IHEM strains could not be evaluated on the Biotyper because of licence restrictions, leaving 73 non‐duplicate isolates for direct MSI‐2 vs MBT comparison. EUCAST E.Def 11.0 micro‐broth dilution determined MICs for eight agents.

Results

MSI‐2 achieved its highest accuracy with PDA day‐7 cultures (45/73, 62%), whereas the liquid Biotyper protocol yielded 49/73 correct identifications (67%) within four days. Accepting low‐confidence scores (≥ 1.7) from either library increased overall accuracy to 73%. MSI‐2 remained superior for N. gypsea (73%) and uniquely detected N. nana (50%), which is absent from the current Biotyper release. Conversely, the Biotyper outperformed MSI‐2 for N. incurvata , N. fulva , and N. praecox . Six very rare species ( N. lorica , N. aenigmatica , N. corniculata , N. duboisii , N. perplicata , N. polymorpha ) were not recognised by either database. Terbinafine displayed the lowest geometric mean MIC (0.009 mg/L); fluconazole and griseofulvin showed the highest values, and one US N. fulva isolate exhibited elevated itraconazole/voriconazole MICs (1 mg/L).

Conclusions

Diagnostic coverage of Nannizzia remains incomplete. Expanding commercial MALDI‐ToF MS libraries with spectra from rare species and performing routine susceptibility testing are essential to optimise patient management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Spectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationAntifungal AgentsArthrodermataceaeMicrobial Sensitivity TestsHumansDermatomycoses

Stichwörter der Autor:innen

NannizziaMALDI‐ToFantifungalsdermatophytesdiagnosticsgeophilic

Substanzen

Antifungal Agents

Autor:innen und Institutionen

  • Guizhou Key Laboratory of Microbiome and Infectious Disease Prevention and Control & Key Laboratory of Environmental Pollution Monitoring and Disease Control, Ministry of Education of Guizhou & School of Basic Medical S…
  • Center of Expertise in Mycology Radboud, University Medical Center/Canisius Wilhelmina Hospital, Nijmegen, the Netherlands.
  • Foundation Atlas of Clinical Fungi, Hilversum, the Netherlands.
  • Department of Medical Mycology, Institute of Dermatology, Chinese Academy of Medical Science & Peking Union Medical College, Nanjing, China.
  • Saxion University of Applied Sciences, Apeldoorn, the Netherlands.
  • Bruker Daltonics GmbH & Co. KG, Bremen, Germany.

ORCID-Profile: Sarah A Ahmed, Sybren de Hoog

Förderung

  • 111 Project
  • National Natural Science Foundation of China
  • International Science and Technology Cooperation Base of Guizhou Province
  • Scientists Workstation Guizhou Province
  • Higher Education Discipline Innovation Project

Zitieren

APA

Tang, C., Kong, X., Jansen, J., Vossgroene, K., Vu, T. L., Oberheitmann, B., Tehupeiory-Kooreman, M., Zhou, S., Zhou, X., Tsui, C. K., Liu, W., Kang, Y., Ahmed, S. A., & de Hoog, S. (2025). Utility of MALDI ‐ ToF MS for Recognition and Antifungal Susceptibility of Nannizzia , an Underestimated Group of Dermatophytes. Mycoses. https://doi.org/10.1111/myc.70117

Vancouver

Tang C, Kong X, Jansen J, Vossgroene K, Vu TL, Oberheitmann B, et al. Utility of MALDI ‐ ToF MS for Recognition and Antifungal Susceptibility of Nannizzia , an Underestimated Group of Dermatophytes. Mycoses. 2025. doi:10.1111/myc.70117

BibTeX
@article{Tang2025,
  author = {Tang, Chao and Kong, Xue and Jansen, Jasmijn and Vossgroene, Katharina and Vu, Thi-Lam-An and Oberheitmann, Boris and Tehupeiory-Kooreman, Marlou and Zhou, Shaoqin and Zhou, Xin and Tsui, Clement Kin-Ming and Liu, Weida and Kang, Yingqian and Ahmed, Sarah A and de Hoog, Sybren},
  title = {Utility of MALDI ‐ ToF MS for Recognition and Antifungal Susceptibility of Nannizzia , an Underestimated Group of Dermatophytes},
  journal = {Mycoses},
  year = {2025},
  doi = {10.1111/myc.70117}
}
Kostenlos starten →